Tuberculous peritonitis after treatment with adalimumab

Scand J Infect Dis. 2008;40(8):677-8. doi: 10.1080/00365540701877320.

Abstract

We present a case of tuberculous peritonitis in a woman with rheumatoid arthritis (RA), treated with adalimumab, and we review the association between anti-tumour necrosis factor (anti-TNF) therapy and tuberculosis. There have been only 2 case reports of peritoneal tuberculosis associated with anti-TNF and only 1 with adalimumab.

Publication types

  • Case Reports

MeSH terms

  • Adalimumab
  • Aged
  • Antibiotics, Antitubercular / therapeutic use
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy*
  • Female
  • Humans
  • Isoniazid / therapeutic use
  • Mycobacterium tuberculosis / isolation & purification
  • Opportunistic Infections / diagnosis
  • Opportunistic Infections / drug therapy
  • Opportunistic Infections / etiology*
  • Peritonitis, Tuberculous / diagnosis
  • Peritonitis, Tuberculous / drug therapy
  • Peritonitis, Tuberculous / etiology*
  • Pyrazinamide / therapeutic use
  • Rifampin / therapeutic use

Substances

  • Antibiotics, Antitubercular
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Pyrazinamide
  • Adalimumab
  • Isoniazid
  • Rifampin